Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Zhi-Lie CAO"'
Autor:
Xiao-Ping Qi, Jian-Qiang Zhao, Xu-Dong Fang, Bi-Jun Lian, Feng Li, Hui-Hong Wang, Zhi-Lie Cao, Wei-Hui Zheng, Juan Cao, Yu Chen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
Abstract Background Germline RET mutations and variants are involved in development of multiple endocrine neoplasia type 2 (MEN2). The present study investigated a spectrum of RET variants, analyzed genotype-phenotype relationships, and evaluated the
Externí odkaz:
https://doaj.org/article/71bc5825d47649a2abd2748da1bf06a3
Autor:
Xiao-Ping Qi, Jian-Zhong Peng, Xiao-Wei Yang, Zhi-Lie Cao, Xiu-Hua Yu, Xu-Dong Fang, Da-Hong Zhang, Jian-Qiang Zhao
Publikováno v:
Endocrine Connections, Vol 7, Iss 9, Pp 998-1005 (2018)
Background: Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in
Externí odkaz:
https://doaj.org/article/a521699a64724f27b4f3f42925549400
Publikováno v:
World Journal of Clinical Cases. 11:2267-2275
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:554-560
Background: Mixed medullary and follicular thyroid carcinoma (MMFC) displays heterogeneous morphological components and immunophenotypical features intermingled within the same lesion, which is rare and most described in the sporadic form. We report
Autor:
Zhi-Lie Cao, Xiu-Hua Yu, Yi-Hua Zhao, Sheng Wang, Xu-Dong Fang, Xiao-Ping Qi, Bai-Ye Jin, Jun Cheng, Peng-Fei Li, Jianqiang Zhao
Publikováno v:
Thyroid. 29:1447-1456
Background: Inherited medullary thyroid carcinoma (MTC) is primarily caused by RET mutations that are commonly localized in exons 5, 8, 10, 11, and 13–16. In this study, we report pedigrees for ind...
Autor:
Hui-Hong Wang, Zhi-Lie Cao, Xiao-Ping Qi, Yu Chen, Feng Li, Juan Cao, Xu-Dong Fang, Wei-Hui Zheng, Bi-Jun Lian, Jianqiang Zhao
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
Background Germline RET mutations and variants are involved in development of multiple endocrine neoplasia type 2 (MEN2). The present study investigated a spectrum of RET variants, analyzed genotype-phenotype relationships, and evaluated their effect
Background Multiple endocrine neoplasia type 2A (MEN2A) is a rare syndrome caused almost by germline RET mutation, and characterized by medullary thyroid carcinoma (MTC), in combination or not with pheochromocytoma (PHEO), hyperparathyroidism (HPTH),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0218a61c4f835fa04c22f37b25e6cf62
https://doi.org/10.21203/rs.3.rs-58755/v1
https://doi.org/10.21203/rs.3.rs-58755/v1
Autor:
Feng Li, Xiao-Ping Qi, Peng-Fei Li, Guang-Ping Wang, Wo-Long Ma, Hong Jia, Er Fu, Zhi-Lie Cao, Jian Guo, Jian-Qiang Zhao, Yi-Hua Zhao
Publikováno v:
Cancer Investigation. 36:141-151
This study systematically reviewed previous literatures and analyzed the genotype-phenotype relationship between the multiple endocrine neoplasia type 2A (MEN 2A)-cutaneous lichen amyloidosis (CLA) and RET/OSMR/IL31RA mutations. RET/OSMR/IL31RA scree
Publikováno v:
Neoplasma; 2021, Vol. 68 Issue 5, p1098-1106, 9p
Publikováno v:
Journal of biosciences. 42(2)
Approximately 98% of patients with multiple endocrine neoplasia type 2A (MEN 2A) have an identifiable RET mutation. Prophylactic or early total thyroidectomy or pheochromocytoma/parathyroid removal in patients can be preventative or curative and has